Clinical Trial Update: Safety and Tolerability of hCBE-11 in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of hCBE-11 in subjects with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• hCBE-11

Snippet

Sponsor: Biogen | Conditions: Tumors | Phase 1 | Status: TERMINATED